INDBInternet News Database 2.5 Updated 1 min ago · 324 sources Show or hide images Light or dark

Dazodalibep Improves Systemic Sjögren Activity in Key Trial

Save Like Comments Compare coverage

Summary

The 1500-mg dose taken every 4 weeks generally outperforms the 3000-mg dose taken every 12 weeks compared with placebo.

Description from Medscape.

Who is covering this

  1. Medscape Center Factuality: Mostly factual US
    Dazodalibep Improves Systemic Sjögren Activity in Key Trial

    The 1500-mg dose taken every 4 weeks generally outperforms the 3000-mg dose taken every 12 weeks compared with placebo.

Comments

Comments need JavaScript.